Sinopharm (company)
Search results
Top News. Bai Zhongquan meets with governor of Hebei province. Sinopharm general manager delivers opening speech at CBioPC2024. Liu Jingzhen meets with Surinamese president.
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
China National Pharmaceutical Group Corporation ( CNPGC ), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.
Jun 10, 2022 · The WHO Strategic Advisory Group of Experts (SAGE) has issued interim recommendations for the use of the Sinopharm vaccine against COVID-19. This article provides a summary of those interim recommendations; you may access the full guidance document here. Here is what you need to know.
China National Pharmaceutical Group Co Ltd (Sinopharm) is a centrally-administered State-owned enterprise under the direct management of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC).
May 7, 2021 · The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine developed by a non-Western country...
Mar 9, 2021 · Sinopharm holds a controlling stake in six publicly traded entities — two listed in Hong Kong, including Sinopharm Holdings, and four on the Chinese mainland. Despite limited uptake so far...
Dec 31, 2020 · Thursday's announcement concerning the vaccine made by the China National Pharmaceutical Group, or Sinopharm, is China's first general approval of a homemade jab - and it is being seen as...
May 7, 2021 · GENEVA, May 7 (Reuters) - The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China's state-owned drugmaker Sinopharm on Friday, bolstering Beijing's push for a...
May 7, 2021 · China’s Sinopharm Group Co. won World Health Organization backing for its Covid-19 vaccine, paving the way for a wider rollout of the shot in countries scrambling for immunizations.
